Publications
Publications
Show Results For
- All HBS Web
(3,291)
- Faculty Publications (1,403)
- November 2003 (Revised September 2008)
- Case
Circle Gastroenterology Products (A)
By: Regina E. Herzlinger and James Weber
A new, minimally invasive medical device has achieved only one-third of its budget. Was the problem one of marketing strategy, sales, reimbursement, and/or clinical trials? View Details
- October 2003 (Revised January 2004)
- Case
BSE in Canada
By: Ray A. Goldberg and Kevin Allison
A cow was determined to have Bovine Spongiform Encephalopathy in Canada, which closed its beef exports to the United States and 39 other countries. What future action should be taken, and how will country of origin specification and traceability take place in the... View Details
- October 2003 (Revised February 2004)
- Case
Launching the European Food Safety Authority
By: Ray A. Goldberg and Hal Hogan
The first food safety commission is established for the European Union. How does it handle food safety, scientific evaluations, and people's attitudes toward scientific changes in food growing and processing--for example, genetically modified organisms? View Details
- October 2003 (Revised March 2008)
- Case
Salick Cardiovascular Centers: Business Plan
By: Regina E. Herzlinger, Kaushik Sen, Alex Tkachenko and Carolyn Wolff
A seasoned health services entrepreneur develops a business plan for a cardiovascular-focused factory. Will it work? View Details
- September 2003
- Case
Allscripts, Inc.
By: William A. Sahlman and Laurence E. Katz
Describes a set of decisions confronting an entrepreneurial team that is considering taking managerial control of Allscripts, a health care venture. The company has gone through nine rounds of external financing and has changed its business model several times. View Details
- September 3, 2003
- Article
Relationship Between Wages and Presence of a Match in Medical Fellowships
By: Muriel Niederle and A. E. Roth
- August 2003 (Revised August 2024)
- Case
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
By: Regina E. Herzlinger and John McDonough
Many health care innovations appear successful; but fail. This is the first case in the Innovating Health Care course that investigates how to create successful health care innovations. It is part of the first module in the course. This module focuses on how to... View Details
- August 2003 (Revised August 2006)
- Case
HealthSouth Corporation
By: Regina E. Herzlinger and Ivan Cheung
Delineates how a for-profit health services business was created. Focuses on sources of financing, the impact of Medicare reimbursement, and Stark laws against fraud and abuse. View Details
- August 2003 (Revised September 2008)
- Background Note
Note on Financing of the U.S. Health Care Sector
By: Regina E. Herzlinger and Jeff Grahling
This course describes the public and private sources of financing of the U.S. health-care sector,and identifies the characteristics of insurance policies, their costs, the structure of the insurance industry, and the role of consultants and brokers. The insurance... View Details
- August 2003 (Revised August 2006)
- Case
New Sector Alliance (A): An Entry into Health Care?
By: Regina E. Herzlinger, Stacy Smollin Schwartz and Jeffrey Cronin
Describes the structure of the U.S. health care system and presents a study of a nonprofit consulting firm that hopes to enter the health care system. Includes descriptions of hospitals, doctors, insurers, medical technology providers, medical devices, pharmaceuticals,... View Details
- August 2003 (Revised March 2004)
- Case
Wintel (A): Cooperation or Conflict
By: David B. Yoffie, Ramon Casadesus-Masanell and Sasha Mattu
Examines the dynamic relationship between two complementors: Intel and Microsoft. Set in 1995, the case asks how Intel and Microsoft should solve a serious division between the two companies that threatens the health of the PC industry. View Details
- August 2003 (Revised August 2006)
- Case
I've Got Rhythm: Selling Cardiac Rhythm Management Devices
By: Regina E. Herzlinger, William Lagor, Christopher Perry and Scott St. Germain
The head of sales and marketing in a large medical devices firm must decide how to assign his sales force. He compares selling in the pharma, specialty pharma, and device industries and analyzes the reasons for the differences. View Details
- July 2003 (Revised August 2003)
- Case
Global Healthcare Exchange
By: Lynda M. Applegate and Jamie Ladge
Founded in March 2000 at the height of the dot-com bubble, Global Healthcare Exchange (GHX) was one of 90 online marketplaces in the health care industry. The company's founders were among the largest suppliers in the industry, including Johnson & Johnson, GE Medical,... View Details
- July 2003 (Revised December 2003)
- Case
Investment Policy at New England Healthcare
By: Jay O. Light, Luis M. Viceira and Akiko M. Mitsui
The Investment Committee of New England Healthcare must decide how to invest three long-term investment pools: a long-term, endowment-type fund and two pension plans. In particular, the committee is evaluating whether the two pension funds--one is a "final salary"... View Details
Keywords: Decisions; Asset Management; Investment; Investment Portfolio; Policy; Taxation; Health Industry; England
- June 2003 (Revised March 2008)
- Case
Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene
By: Regina E. Herzlinger and Marc Aquino
Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations. View Details
- June 2003 (Revised November 2003)
- Case
Siemens Medical Solutions: Strategic Turnaround
By: D. Quinn Mills and Julian Kurz
Describes how Siemens Medical Solutions (MED) accomplished a remarkable turnaround from a money-losing operation to one of Siemens' most profitable divisions. By late 1996, a challenging market environment in the health care industry as well as inefficiencies in the... View Details
- June 2003 (Revised May 2006)
- Case
Cipla
By: Rohit Deshpande and Laura Winig
The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line... View Details
- June 2003 (Revised August 2008)
- Teaching Note
Children's Hospital and Clinics (TN)
By: Amy C. Edmondson, Michael Roberto and Laura Feldman
Teaching Note for (9-302-050). View Details